Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8835423 Azepine inhibitors of janus kinases

Patent 8835423 was granted and assigned to Incyte on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Incyte

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8835423

Patent Inventor Names

James D. Rodgers0

Andrew P. Combs0

Argyrios G. Arvanitis0

Darius J. Robinson0

Richard B. Sparks0

Date of Patent

September 16, 2014

Patent Application Number

14032629

Date Filed

September 20, 2013

Patent Citations Received

‌

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

‌

US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors

‌

US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

Patent Primary Examiner

‌

Charanjit Aulakh

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8835423 Azepine inhibitors of janus kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API